Speclipse, Inc.
Speclipse was established to make it easier for people to diagnose disease.
Our company was chosen as one of the "2018 TOP 10 Dermatology Solution Providers" by MedTech Outlook, a healthcare magazine in the US, for our technology that analyzes skin cancer based on Speclipse's laser-induced plasma spectroscopy and AI.
Speclipse is growing into a global medical device company that conducts research to expand the medical application of technology into the blood market, starting with skin cancer.
USA